Cargando…
Small Alphaherpesvirus Latency-Associated Promoters Drive Efficient and Long-Term Transgene Expression in the CNS
Recombinant adeno-associated viruses (rAAVs) are used as gene therapy vectors to treat central nervous system (CNS) diseases. Despite their safety and broad tropism, important issues need to be corrected such as the limited payload capacity and the lack of small gene promoters providing long-term, p...
Autores principales: | Maturana, Carola J., Verpeut, Jessica L., Pisano, Thomas J., Dhanerawala, Zahra M., Esteves, Andrew, Enquist, Lynn W., Engel, Esteban A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7191541/ https://www.ncbi.nlm.nih.gov/pubmed/32368565 http://dx.doi.org/10.1016/j.omtm.2020.04.004 |
Ejemplares similares
-
Novel tool to quantify with single-cell resolution the number of incoming AAV genomes co-expressed in the mouse nervous system
por: Maturana, Carola J., et al.
Publicado: (2021) -
Directional Spread of Alphaherpesviruses in the Nervous System
por: Kramer, Tal, et al.
Publicado: (2013) -
CRISPR/Cas9-Constructed Pseudorabies Virus Mutants Reveal the Importance of UL13 in Alphaherpesvirus Escape from Genome Silencing
por: Van Cleemput, Jolien, et al.
Publicado: (2021) -
In vitro model for lytic replication, latency, and transformation of an oncogenic alphaherpesvirus
por: Schermuly, Julia, et al.
Publicado: (2015) -
Interferon Alpha Induces Establishment of Alphaherpesvirus Latency in Sensory Neurons In Vitro
por: De Regge, Nick, et al.
Publicado: (2010)